Genetic testing can be a valuable part of understanding a neurological condition. It may help clarify a diagnosis, estimate the chance that a condition could affect other family members, or guide how a condition is managed. It cannot answer every question, and it does not always provide a definite result. This page explains, in plain terms, how testing works and what to realistically expect from it.
Why Genetic Testing Is Not One-Size-Fits-All
There is no single “genetic test” that applies to every patient. Different symptoms, family histories, and suspected conditions call for different testing strategies — a test well suited to one situation may be the wrong choice, or simply unhelpful, for another. For this reason, the appropriate test is chosen only after a clinical evaluation, not before it.
Common Types of Genetic Testing
Single-gene testing looks at one specific gene already strongly suspected based on the clinical picture.
Gene panel testing examines a curated group of genes known to be associated with a particular type of condition, such as a group of neuromuscular or movement disorders.
Repeat expansion testing looks for a specific kind of genetic change — an abnormally repeated DNA sequence — associated with conditions such as certain hereditary ataxias.
Whole exome sequencing examines the protein-coding regions across nearly all genes, useful when the clinical picture doesn’t point to one clear candidate gene.
Whole genome sequencing examines coding and non-coding DNA more broadly, and may be considered when exome sequencing has not been informative.
Long-read sequencing is a newer sequencing method well suited to detecting certain repeat expansions or structurally complex genetic regions that are difficult to resolve with standard methods.
What Results May Mean
Genetic test results generally fall into a few categories:
- Positive / pathogenic — a genetic change is identified that is known to cause, or strongly contribute to, the condition in question.
- Negative — no disease-causing change was identified in the regions tested. This does not always rule out a genetic cause; see Limitations below.
- Variant of uncertain significance — a genetic change was found, but it is not yet clear whether it causes disease. These findings are not treated as a diagnosis on their own.
- Incidental or secondary findings — occasionally, testing uncovers information unrelated to the original clinical question. Whether and how such findings are shared is discussed with you in advance.
Why Counseling Matters
Genetic counseling is part of testing, not something added on after a result arrives. It addresses:
- Medical implications — what a result does and does not mean for your diagnosis and care
- Family implications — what a result might mean for relatives, and whether they may wish to consider testing themselves
- Emotional implications — genetic information can be difficult to receive, and support in processing it is part of this care
- Privacy and consent — what will be tested, who will see the results, and how the information will and will not be used
Limitations
Genetic testing has real limits, and being upfront about them is part of responsible care:
- A negative result does not always rule out a genetic condition — it may mean the specific test used could not detect the cause
- Some findings remain genuinely uncertain, even after testing is complete
- Availability, cost, and turnaround time vary by test type, and some testing is coordinated through laboratories overseas